AzTrials
AzTrials

Comorbidities and Coexisting ConditionsNCT04375189

High Risk Outpatient Intern-led Care (HeROIC) Clinic Initiative

A study testing High Risk Clinic in people with Comorbidities and Coexisting Conditions and Risk Reduction, run by Johns Hopkins University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Background: A small subset of the patient population is responsible for a significant proportion of healthcare expenditures. These patients are cared for in academic medical centers by internal medicine residents however there has been no research to date about the education or the management of patients with complex… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
High Risk Clinic
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Jul 2016to 20 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 6 medical comorbidities
  • ≥ 2 admissions past 6 months or ≥ 4 past 1 year
  • New or returning patient in resident primary care clinic

Who cannot join

  • Primary mental health disease driving hospitalizations

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Johns Hopkins Outpatient Center

    Baltimore, Maryland, 21287

Other trials in United States

About this study

Official title: Impact of a Novel Complex Outpatient Clinic Setup on Patient Outcomes and Intern Education

Background: A small subset of the patient population is responsible for a significant proportion of healthcare expenditures. These patients are cared for in academic medical centers by internal medicine residents however there has been no research to date about the education or the management of patients with complex multimorbidity in the outpatient setting.

Objective: To evaluate the impact of the High Risk Outpatient Intern-led Care (HeROIC) Clinic on internal medicine interns' perceived ability to manage complex outpatients as well as pre and post intervention total patient healthcare cost.

Methods: The investigators created the HeROIC outpatient clinic environment to comprise longer visit time slots, "bedside" presentations, and team-based care (one intern primary care provider, one secondary intern, and one longitudinal attending). All non-preliminary interns based at one primary care site participated in the intervention while interns at a second site continued to practice in the usual outpatient clinic environment. The interns in the HeROIC clinic arm assumed the roles of primary care providers for 34 complex patients in total. The primary outcome was the perceived confidence in the management of complex outpatients as assessed by a survey. Secondary outcomes included perceptions about the ability to provide high-quality outpatient and evidence-based outpatient care, as well as statewide pre-post patient healthcare cost data.

Being tested
High Risk Clinic
Keywords
High utilizer, High needs, Multimorbidity, Intensive outpatient care, Resident education
Medical subject headings
Risk Reduction Behavior, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High Risk ClinicOther

    Subgroup of primary care clinic where patients have longer time slots, supervision by one longitudinal attending, "bedside" presentations

Study groups in NCT04375189
Study groupRoleWhat they receive
Standard CareNo interventionNot described
Complex Clinic ArmExperimentalNot described
Receives: Other: High Risk Clinic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Inpatient or ER visits

    Presentations to the ER and hospitalizations

    Measured: Up to 2 years post enrollment

Secondary outcomes (1)
  1. Total medical cost

    Total medical costs (Outpatient, Inpatient, Imaging, Labs)

    Measured: Up to 2 years post enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2020
  2. Study start1 Jul 2016
  3. Primary completion1 Jul 2022 (estimated)
  4. Study completion20 Jul 2022

Why it stopped: Covid-19, funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04375189
Sponsor's protocol ID
IRB00137125
Status last verified
Jul 2022
First submitted
1 May 2020
Last updated
25 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing High Risk Clinic in people with Comorbidities and Coexisting Conditions and Risk Reduction, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 25 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Inpatient or ER visits (time frame: Up to 2 years post enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in